Search Results 621-630 of 18314 for Hepatitis b

1. A Study of Ibrutinib as Prophylaxis for Chronic Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (allo-HCT) - Mayo Clinic

   Active hepatitis B or C infection. Note: A detailed assessment of Hepatitis B/C medical history and risk factors must be done at screening for all ...

2. A Study to Investigate the Safety and Tolerability of REGN1979 in Patients With CD20+ B-Cell Malignancies - Mayo Clinic

   ... hepatitis B virus (HBV) or hepatitis C virus (HCV). Patients with hepatitis B (HepBsAg+) who have controlled infection (serum hepatitis B virus DNA that is ...

3. A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors - Mayo Clinic

   ... hepatitis B (HBV), or hepatitis C virus (HCV): a. Patients with HIV are excluded. a.b. Patients who are hepatitis B surface antigen positive are eligible if ...

4. Publications - Remzi Bag, M.D. - Mayo Clinic

   Donor derived hepatitis B virus infection: Analysis of the Organ Procurement & Transplantation Network/United Network for Organ Sharing Ad Hoc Disease ...

5. A Study to Evaluate AFPᶜ³³²T in Advanced HCC - Mayo Clinic

   Active viral hepatitis. Subjects positive for hepatitis B surface antigen not on antiviral treatment/prophylaxis or subjects with detectable hepatitis B DNA:.

6. Blanca C. Lizaola-Mayo, M.D. - Doctors and Medical Staff

   Conditions treated · Autoimmune hepatitis; Fatty liver disease; Hepatic encephalopathy · Hepatitis B · Hepatitis C · Hepatocellular carcinoma · Procedures ...

7. GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma - Mayo Clinic

   * Hepatitis B virus (HBV): Patients with positive hepatitis B surface antigen (HBsAg) are excluded. Patients with positive hepatitis B core antibody (anti ...

8. ACP-196 in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies - Mayo Clinic

   Participation eligibility · Subjects who are hepatitis B core antibody (anti-HBc) positive and who are surface antigen negative will need to have a negative ...

9. Channa R. Jayasekera, M.D. - Doctors and Medical Staff - Mayo Clinic

   Conditions treated. Alcoholic liver disease; Cirrhosis · Hemochromatosis · Hepatic encephalopathy · Hepatitis B · Hepatitis C · Hepatocellular carcinoma ...

10. Cancer Physicians - Medical Professionals - Mayo Clinic

    Vijay Shah, M.D.. Rochester, MN. Area of Focus: Liver transplant, Cirrhosis, Portal hypertension, Liver cancer, Alcoholic hepatitis, Hepatic encephalopathy ...